Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Frankenius Equity AB files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Michael P. Stansky - $3.01M in TLSI purchases and sales in the last 12 months
- Mary T. Szela - $307K in TLSI purchases and sales in the last 12 months
- Mats Wahlstrom - $152K in TLSI purchases and sales in the last 12 months
- William Valle - $125K in TLSI purchases and sales in the last 12 months
- Gary B. Gordon - $65K in TLSI purchases and sales in the last 12 months
- David Patience - $32K in TLSI purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
What is Frankenius Equity AB?
Frankenius Equity AB is an investment firm, tracked as 10% Owner of TriSalus Life Sciences, Inc. (TLSI). InsiderAlpha holds 2 primary Form 4 filings for it, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Frankenius Equity AB last file a Form 4?
The most recent primary Form 4 on record is dated 20 April 2026, one of 2 filings going back to 2024.
Has Frankenius Equity AB been buying or selling stock?
Recorded transactions: 1 open-market purchase ($250K) and 0 open-market sales across all tracked filings.
